Literature DB >> 12524203

Nanoparticle-mediated gene delivery to tumour neovasculature.

Andrew R Reynolds1, S Moein Moghimi, Kairbaan Hodivala-Dilke.   

Abstract

The alpha(v)beta(3) integrin is a potential pharmacological target for anti-angiogenic therapy. A recent report describes the use of alpha(v)beta(3)-targeted nanoparticles to deliver a gene to tumour vasculature selectively. This resulted in substantial tumour regression in several experimental mouse tumour models. Hence, this approach has great potential for the treatment of human cancer.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12524203     DOI： 10.1016/s1471-4914(02)00004-7

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN： 1471-4914            Impact factor:   11.951


  13 in total

Review 1.  Insight into nanoparticle cellular uptake and intracellular targeting.

Authors:  Basit Yameen; Won Il Choi; Cristian Vilos; Archana Swami; Jinjun Shi; Omid C Farokhzad
Journal:  J Control Release       Date:  2014-06-28       Impact factor: 9.776

2.  Radiation-induced galectin-1 by endothelial cells: a promising molecular target for preferential drug delivery to the tumor vasculature.

Authors:  Meenakshi Upreti; Azemat Jamshidi-Parsian; Scott Apana; Marc Berridge; Daniel A Fologea; Nathan A Koonce; Ralph L Henry; Robert J Griffin
Journal:  J Mol Med (Berl)       Date:  2012-10-23       Impact factor: 4.599

3.  Mesoporous Silica Nanoparticles for Cancer Therapy: Energy-Dependent Cellular Uptake and Delivery of Paclitaxel to Cancer Cells.

Authors:  Jie Lu; Monty Liong; Sean Sherman; Tian Xia; Michael Kovochich; Andre E Nel; Jeffrey I Zink; Fuyuhiko Tamanoi
Journal:  Nanobiotechnology       Date:  2007-05-01

4.  Synthesis, characterization, and in vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled delivery of doxorubicin.

Authors:  Abolfazl Akbarzadeh; Nosratollah Zarghami; Haleh Mikaeili; Davoud Asgari; Amir Mohammad Goganian; Hanie Khaksar Khiabani; Mohammad Samiei; Soodabeh Davaran
Journal:  Nanotechnol Sci Appl       Date:  2012-02-07

Review 5.  Novel technologies for antiangiogenic drug delivery in the brain.

Authors:  Ofra Benny; Pouya Pakneshan
Journal:  Cell Adh Migr       Date:  2009-04-06       Impact factor: 3.405

6.  Anti-HER2 scFv-Directed Extracellular Vesicle-Mediated mRNA-Based Gene Delivery Inhibits Growth of HER2-Positive Human Breast Tumor Xenografts by Prodrug Activation.

Authors:  Jing-Hung Wang; Alexis V Forterre; Jinjing Zhao; Daniel O Frimannsson; Alain Delcayre; Travis J Antes; Bradley Efron; Stefanie S Jeffrey; Mark D Pegram; A C Matin
Journal:  Mol Cancer Ther       Date:  2018-02-26       Impact factor: 6.261

7.  Extracellular Vesicle-Mediated In Vitro Transcribed mRNA Delivery for Treatment of HER2+ Breast Cancer Xenografts in Mice by Prodrug CB1954 without General Toxicity.

Authors:  Alexis V Forterre; Jing-Hung Wang; Alain Delcayre; Kyuri Kim; Carol Green; Mark D Pegram; Stefanie S Jeffrey; A C Matin
Journal:  Mol Cancer Ther       Date:  2020-01-15       Impact factor: 6.261

8.  Treatment of oral squamous cell carcinoma using anti-HER2 immunonanoshells.

Authors:  Reza Fekrazad; Neda Hakimiha; Enice Farokhi; Mohammad Javad Rasaee; Mehdi Shafiee Ardestani; Katayoun A M Kalhori; Farzaneh Sheikholeslami
Journal:  Int J Nanomedicine       Date:  2011-11-09

9.  Adriamycin release from poly(lactide-coglycolide)-polyethylene glycol nanoparticles: synthesis, and in vitro characterization.

Authors:  Soodabeh Davaran; Mohammad R Rashidi; Behzad Pourabbas; Mahin Dadashzadeh; Naser Moti Haghshenas
Journal:  Int J Nanomedicine       Date:  2006

10.  Essential role for endocytosis in the growth factor-stimulated activation of ERK1/2 in endothelial cells.

Authors:  Morgane Gourlaouen; Jonathan C Welti; Naveen S Vasudev; Andrew R Reynolds
Journal:  J Biol Chem       Date:  2013-01-22       Impact factor: 5.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.